Company: FTII
Filing Date: 2025-04-09
Form Type: 10-K
Source: 0001641172-25-003384
Chunk: 417

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-04-09
Form: 10-K
Item: Item 1A
Chunk 417
---
 placed in the Trust Account in connection with the Company’s initial
public offering and any Extension Payments, as well as any interest earned thereon, will not be used to pay for the Excise Tax.

Company’s
Combination Period ending on August 18, 2025 contravened Nasdaq rules and, as a result, Nasdaq suspended trading Company’s securities
or delisted Company’s securities from Nasdaq on February 26, 2025. The Company expects that Nasdaq will file a Form 25-NSE with
the SEC to delist its securities, and the Company’s securities will be quoted on the over-the-counter market. The Company’s
common stock would be deemed a “penny” stock and the Company may become subject to the requirements of Rule 419. This may
adversely affect the liquidity and trading of our securities and may impact our ability to complete a business combination.

Nasdaq
IM-5101-2 requires that Company, a special purpose acquisition company, complete one or more business combinations within 36 months of
the effectiveness of its initial public offering registration statement, which, in the case of Company, would be February 14, 2025. The
Company’s Combination Period ending on August 18, 2025 contravenes Nasdaq IM-5101-2 and, as a result, on February 26, 2025 Nasdaq
suspended trading Company’s securities. The Company expects that Nasdaq will file a Form 25-NSE with the SEC to delist its securities,
and that the delisting will become effective ten (10) days after Nasdaq files the Form 25-NSE with the SEC to complete the delisting.
The Company’s common stock will be quoted on the over-the-counter market and would be deemed a “penny” stock and the
Company may become subject to the requirements of Rule 419. This may adversely affect the liquidity and trading of our securities and
may impact our ability to complete a business combination. Company intends to make a listing application for the securities of the combined
company to be traded on Nasdaq. However, there is no guarantee that such listing application will be successful.

10

Other
potential material adverse consequences of being quoted on the over-the-counter market include:

●
a limited availability of market quotations for our securities;

●
reduced liquidity for our securities;

●
a determination that our shares of common stock are a “penny stock” which will require brokers trading